Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2016, Article ID 7926264, 9 pages
http://dx.doi.org/10.1155/2016/7926264
Review Article

Current Treatment Approaches to HCC with a Special Consideration to Transplantation

1Department of Hepatobiliary and Pancreatic Surgery, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford OX3 7LE, UK
2The Liver Unit, University Hospital Birmingham NHS Foundation Trust-Queen Elizabeth, Birmingham 15 2TH, UK

Received 16 March 2016; Accepted 19 May 2016

Academic Editor: Parmjeet Randhawa

Copyright © 2016 N. Bhardwaj et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, Cancer Incidence, Mortality and Prevalence Worldwide, IARC Cancer Base 5(Version 2), IARC Press, Lyon, France, 2004.
  2. Office for National Statistics, Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2006, England, 2009, http://www.cancerresearchuk.org/about-cancer/type/liver-cancer/about/risks-and-causes-of-liver-cancer.
  3. S. D. Taylor-Robinson, G. R. Foster, S. Arora, S. Hargreaves, and H. C. Thomas, “Increase in primary liver cancer in the UK, 1979–94,” The Lancet, vol. 350, no. 9085, pp. 1142–1143, 1997. View at Google Scholar · View at Scopus
  4. B. Q. Starley, C. J. Calcagno, and S. A. Harrison, “Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection,” Hepatology, vol. 51, no. 5, pp. 1820–1832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Lin, K. Hoffmann, and P. Schemmer, “Treatment of hepatocellular carcinoma: a systematic review,” Liver Cancer, vol. 1, no. 3-4, pp. 144–158, 2012. View at Publisher · View at Google Scholar
  7. F. Cauchy, D. Fuks, and J. Belghiti, “HCC: current surgical treatment concepts,” Langenbeck's Archives of Surgery, vol. 397, no. 5, pp. 681–695, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. European Association for the Study of the L and European Organisation for R, “EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma,” Journal of Hepatology, vol. 56, no. 4, pp. 908–943, 2012. View at Publisher · View at Google Scholar
  9. N. Nagasue, H. Yukaya, Y. Ogawa, H. Kohno, and T. Nakamura, “Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis,” Annals of Surgery, vol. 206, no. 1, pp. 30–39, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-N. Yeh, W.-C. Lee, and M.-F. Chen, “Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital,” Annals of Surgical Oncology, vol. 10, no. 9, pp. 1070–1076, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Belghiti, F. Regimbeau, F. Durand et al., “Resection of hepatocellular carcinoma: a european experience on 328 cases,” Hepato-Gastroenterology, vol. 49, no. 43, pp. 41–46, 2002. View at Google Scholar · View at Scopus
  12. A. L. Young, R. Adair, K. R. Prasad, G. J. Toogood, and J. P. A. Lodge, “Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes,” Journal of the American College of Surgeons, vol. 214, no. 2, pp. 174–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Edge, D. R. Byrd, C. C. Compton, A. G. Fritz, F. L. Greene, and A. Trotti, AJCC Cancer Staging Handbook, Springer, New York, NY, USA, 7th edition, 2010.
  14. C. Gallo, “A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators,” Hepatology, vol. 28, no. 3, pp. 751–755, 1998. View at Google Scholar · View at Scopus
  15. T. W. T. Leung, A. M. Y. Tang, B. Zee et al., “Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients,” Cancer, vol. 94, no. 6, pp. 1760–1769, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Chevret, J.-C. Trinchet, D. Mathieu, A. A. Rached, M. Beaugrand, and C. Chastang, “A new prognostic classification for predicting survival in patients with hepatocellular carcinoma,” Journal of Hepatology, vol. 31, no. 1, pp. 133–141, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Kitai, M. Kudo, Y. Minami et al., “Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan integrated staging score, the conventional Japan integrated staging score and the BALAD score,” Oncology, vol. 75, no. 1, pp. 83–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Y. Yao, L. Ferrell, N. M. Bass et al., “Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival,” Hepatology, vol. 33, no. 6, pp. 1394–1403, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. J. I. Herrero, B. Sangro, J. Quiroga et al., “Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma,” Liver Transplantation, vol. 7, no. 7, pp. 631–636, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Roayaie, J. S. Frischer, S. H. Emre et al., “Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters,” Annals of Surgery, vol. 235, no. 4, pp. 533–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. N. M. Kneteman, J. Oberholzer, M. Al Saghier et al., “Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma,” Liver Transplantation, vol. 10, no. 10, pp. 1301–1311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Y. Yao, L. Xiao, N. M. Bass, R. Kerlan, N. L. Ascher, and J. P. Roberts, “Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging,” American Journal of Transplantation, vol. 7, no. 11, pp. 2587–2596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Onaca, G. L. Davis, R. M. Goldstein, L. W. Jennings, and G. B. Klintmalm, “Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the international registry of hepatic tumors in liver transplantation,” Liver Transplantation, vol. 13, no. 3, pp. 391–399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. U. Cillo, A. Vitale, F. Grigoletto et al., “Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria,” American Journal of Transplantation, vol. 7, no. 4, pp. 972–981, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Mazzaferro, J. M. Llovet, R. Miceli et al., “Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis,” The Lancet Oncology, vol. 10, no. 1, pp. 35–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. J. Guiteau, R. T. Cotton, W. K. Washburn et al., “An early regional experience with expansion of milan criteria for liver transplant recipients,” American Journal of Transplantation, vol. 10, no. 9, pp. 2092–2098, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Bruix, M. Sherman, and American Association for the Study of Liver D, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Mazzaferro, E. Regalia, R. Doci et al., “Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis,” The New England Journal of Medicine, vol. 334, no. 11, pp. 693–699, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Imamura, Y. Matsuyama, Y. Miyagawa et al., “Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinoma,” British Journal of Surgery, vol. 86, no. 8, pp. 1032–1038, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-M. Regimbeau, R. Kianmanesh, O. Farges, F. Dondero, A. Sauvanet, and J. Belghiti, “Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma,” Surgery, vol. 131, no. 3, pp. 311–317, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Eguchi, T. Kanematsu, S. Arii et al., “Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey,” Surgery, vol. 143, no. 4, pp. 469–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Torzilli, J. Belghiti, N. Kokudo et al., “A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC east-west study group,” Annals of Surgery, vol. 257, no. 5, pp. 929–937, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Capussotti, A. Muratore, M. Amisano, R. Polastri, H. Bouzari, and P. Massucco, “Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival—a European single center experience,” European Journal of Surgical Oncology, vol. 31, no. 9, pp. 986–993, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Utsunomiya, M. Shimada, K.-I. Taguchi et al., “Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma,” Journal of the American College of Surgeons, vol. 190, no. 3, pp. 331–335, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Huang, S. S. Raman, N. Vuong, J. W. Sayre, and D. S. K. Lu, “Utility of breath-hold fast-recovery fast spin-echo T2 versus respiratory-triggered fast spin-echo T2 in clinical hepatic imaging,” American Journal of Roentgenology, vol. 184, no. 3, pp. 842–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Capussotti, A. Ferrero, L. Viganò, R. Polastri, and M. Tabone, “Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines,” European Journal of Surgical Oncology, vol. 35, no. 1, pp. 11–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Ringe, R. Pichlmayr, C. Wittekind, and G. Tusch, “Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients,” World Journal of Surgery, vol. 15, no. 2, pp. 270–285, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Iwatsuki, T. E. Starzl, D. G. Sheahan et al., “Hepatic resection versus transplantation for hepatocellular carcinoma,” Annals of Surgery, vol. 214, no. 3, pp. 221–229, 1991. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Mazzaferro, S. Bhoori, C. Sposito et al., “Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience,” Liver Transplantation, vol. 17, supplement 2, pp. S44–S57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. W. Hemming, M. S. Cattral, A. I. Reed, W. J. Van der Werf, P. D. Greig, and R. J. Howard, “Liver transplantation for hepatocellular carcinoma,” Annals of Surgery, vol. 233, no. 5, pp. 652–659, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. J. M. Llovet, J. Bruix, J. Fuster et al., “Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power,” Hepatology, vol. 27, no. 6, pp. 1572–1577, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Y. Yoo, C. H. Patt, J.-F. Geschwind, and P. J. Thuluvath, “The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1987 and 2001: 5-Year survival has improved significantly with time,” Journal of Clinical Oncology, vol. 21, no. 23, pp. 4329–4335, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. R. B. Freeman Jr., R. H. Wiesner, A. Harper et al., “The new liver allocation system: moving toward evidence-based transplantation policy,” Liver Transplantation, vol. 8, no. 9, pp. 851–858, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. S. S. Patel, A. K. Arrington, S. McKenzie et al., “Milan criteria and UCSF criteria: a preliminary comparative study of liver transplantation outcomes in the United States,” International Journal of Hepatology, vol. 2012, Article ID 253517, 7 pages, 2012. View at Publisher · View at Google Scholar
  45. J. P. Duffy, A. Vardanian, E. Benjamin et al., “Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA,” Annals of Surgery, vol. 246, no. 3, pp. 502–509, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Y. Leung, A. X. Zhu, F. D. Gordon et al., “Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study,” Liver Transplantation, vol. 10, no. 11, pp. 1343–1354, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Decaens, F. Roudot-Thoraval, S. Hadni-Bresson et al., “Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time,” Liver Transplantation, vol. 12, no. 12, pp. 1761–1769, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Schwartz, “Liver transplantation for hepatocellular carcinoma,” Gastroenterology, vol. 127, no. 5, supplement 1, pp. S268–S276, 2004. View at Google Scholar
  49. NHS Blood and Transplant Liver Advisory Group, “Liver transplantation: selection criteria and recipient registration,” Policy 195/4, 2014. View at Google Scholar
  50. J. W. Jang, C. R. You, C. W. Kim et al., “Benefit of downsizing hepatocellular carcinoma in a liver transplant population,” Alimentary Pharmacology & Therapeutics, vol. 31, no. 3, pp. 415–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Germani, K. Gurusamy, M. Garcovich et al., “Which matters most: number of tumors, size of the largest tumor, or total tumor volume?” Liver Transplantation, vol. 17, supplement 2, pp. S58–S66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. K. V. Menon, A. R. Hakeem, and N. D. Heaton, “Review article: liver transplantation for hepatocellular carcinoma—a critical appraisal of the current worldwide listing criteria,” Alimentary Pharmacology & Therapeutics, vol. 40, no. 8, pp. 893–902, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. A. R. Hakeem, R. S. Young, G. Marangoni, J. P. A. Lodge, and K. R. Prasad, “Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma,” Alimentary Pharmacology and Therapeutics, vol. 35, no. 9, pp. 987–999, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. P. S. Kamath, R. H. Wiesner, M. Malinchoc et al., “A model to predict survival in patients with end-stage liver disease,” Hepatology, vol. 33, no. 2, pp. 464–470, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Sharma, V. Balan, J. L. Hernandez et al., “Liver transplantation for hepatocellular carcinoma: the MELD impact,” Liver Transplantation, vol. 10, no. 1, pp. 36–41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Ravaioli, G. L. Grazi, G. Ballardini et al., “Liver transplantation with the Meld system: a prospective study from a single European center,” American Journal of Transplantation, vol. 6, no. 7, pp. 1572–1577, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf.
  58. D. M. Levi, A. G. Tzakis, P. Martin et al., “Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era,” Journal of the American College of Surgeons, vol. 210, no. 5, pp. 727–734, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Sharma, A. M. Harper, J. L. Hernandez et al., “Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation,” American Journal of Transplantation, vol. 6, no. 8, pp. 1957–1962, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. J. M. Llovet, J. Fuster, and J. Bruix, “Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation,” Hepatology, vol. 30, no. 6, pp. 1434–1440, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Galuppo, A. McCall, and R. Gedaly, “The role of bridging therapy in hepatocellular carcinoma,” International Journal of Hepatology, vol. 2013, Article ID 419302, 8 pages, 2013. View at Publisher · View at Google Scholar
  62. V. Mazzaferro, C. Battiston, S. Perrone et al., “Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study,” Annals of Surgery, vol. 240, no. 5, pp. 900–909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. R. J. Fontana, H. Hamidullah, H. Nghiem et al., “Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation,” Liver Transplantation, vol. 8, no. 12, pp. 1165–1174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. D. S. K. Lu, N. C. Yu, S. S. Raman et al., “Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation,” Hepatology, vol. 41, no. 5, pp. 1130–1137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Y. Yao, M. Kinkhabwala, J. M. LaBerge et al., “The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma,” American Journal of Transplantation, vol. 5, no. 4, pp. 795–804, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Bharat, D. B. Brown, J. S. Crippin et al., “Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival,” Journal of the American College of Surgeons, vol. 203, no. 4, pp. 411–420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. J. M. Llovet, M. Schwartz, and V. Mazzaferro, “Resection and liver transplantation for hepatocellular carcinoma,” Seminars in Liver Disease, vol. 25, no. 2, pp. 181–200, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. E. A. Pomfret, K. Washburn, C. Wald et al., “Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States,” Liver Transplantation, vol. 16, no. 3, pp. 262–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. I. W. Graziadei, H. Sandmueller, P. Waldenberger et al., “Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome,” Liver Transplantation, vol. 9, no. 6, pp. 557–563, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Cescon, A. Cucchetti, M. Ravaioli, and A. D. Pinna, “Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate,” Journal of Hepatology, vol. 58, no. 3, pp. 609–618, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Belghiti, A. Cortes, E. K. Abdalla et al., “Resection prior to liver transplantation for hepatocellular carcinoma,” Annals of Surgery, vol. 238, no. 6, pp. 883–893, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. D. L. Chan, N. A. Alzahrani, D. L. Morris, and T. C. Chua, “Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 29, no. 1, pp. 31–41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. Zhu, J. Dong, W.-L. Wang, M.-X. Li, and Y. Lu, “Short- and long-term outcomes after salvage liver transplantation versus primary liver transplantation for hepatocellular carcinoma: a meta-analysis,” Transplantation Proceedings, vol. 45, no. 9, pp. 3329–3342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. R. S. Brown Jr., “Live donors in liver transplantation,” Gastroenterology, vol. 134, no. 6, pp. 1802–1813, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Siegler, M. C. Simmerling, J. H. Siegler, and D. C. Cronin II, “Recipient deaths during donor surgery: a new ethical problem in living donor liver transplantation (LDLT),” Liver Transplantation, vol. 12, no. 3, pp. 358–360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. R. M. Ghobrial, C. E. Freise, J. F. Trotter et al., “Donor morbidity after living donation for liver transplantation,” Gastroenterology, vol. 135, no. 2, pp. 468–476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. F. P. Sarasin, P. E. Majno, J. M. Llovet, J. Bruix, G. Mentha, and A. Hadengue, “Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective,” Hepatology, vol. 33, no. 5, pp. 1073–1079, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. N. Akamatsu, Y. Sugawara, and N. Kokudo, “Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma,” World Journal of Hepatology, vol. 6, no. 9, pp. 626–631, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. L. Sandhu, C. Sandroussi, M. Guba et al., “Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence,” Liver Transplantation, vol. 18, no. 3, pp. 315–322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. R. C. Grant, L. Sandhu, P. R. Dixon, P. D. Greig, D. R. Grant, and I. D. Mcgilvray, “Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis,” Clinical Transplantation, vol. 27, no. 1, pp. 140–147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. W. Liang, L. Wu, X. Ling et al., “Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis,” Liver Transplantation, vol. 18, no. 10, pp. 1226–1236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. W. C. Chapman, M. B. Majella Doyle, J. E. Stuart et al., “Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation,” Annals of Surgery, vol. 248, no. 4, pp. 617–624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. F. Y. Yao, R. K. Kerlan Jr., R. Hirose et al., “Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis,” Hepatology, vol. 48, no. 3, pp. 819–827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Ravaioli, G. L. Grazi, F. Piscaglia et al., “Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria,” American Journal of Transplantation, vol. 8, no. 12, pp. 2547–2557, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. A. N. Gordon-Weeks, A. Snaith, T. Petrinic, P. J. Friend, A. Burls, and M. A. Silva, “Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria,” British Journal of Surgery, vol. 98, no. 9, pp. 1201–1208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. W. Y. Lau, E. C. H. Lai, and T. W. T. Leung, “Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review,” International Journal of Radiation Oncology, Biology, Physics, vol. 81, no. 2, pp. 460–467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. K. P. Croome, W. Wall, N. Chandok, G. Beck, P. Marotta, and R. Hernandez-Alejandro, “Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts,” Liver Transplantation, vol. 19, no. 11, pp. 1214–1223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Jay, D. Ladner, E. Wang et al., “A comprehensive risk assessment of mortality following donation after cardiac death liver transplant—an analysis of the national registry,” Journal of Hepatology, vol. 55, no. 4, pp. 808–813, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. H. P. Grewal, D. L. Willingham, J. Nguyen et al., “Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience,” Liver Transplantation, vol. 15, no. 9, pp. 1028–1035, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. D. P. Foley, L. A. Fernandez, G. Leverson et al., “Donation after cardiac death: the University of Wisconsin experience with liver transplantation,” Annals of Surgery, vol. 242, no. 5, pp. 724–731, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. D. Monbaliu, T. Crabbé, T. Roskams, J. Fevery, C. Verwaest, and J. Pirenne, “Livers from non-heart-beating donors tolerate short periods of warm ischemia,” Transplantation, vol. 79, no. 9, pp. 1226–1230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Net, R. Valero, R. Almenara et al., “The effect of normothermic recirculation is mediated by ischemic preconditioning in NHBD liver transplantation,” American Journal of Transplantation, vol. 5, no. 10, pp. 2385–2392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. P. Dutkowski, W. G. Polak, P. Muiesan et al., “First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants,” Annals of Surgery, vol. 262, no. 5, pp. 764–771, 2015. View at Publisher · View at Google Scholar
  94. A. C. Westerkamp, N. Karimian, A. P. Matton et al., “Oxygenated hypothermic machine perfusion after static cold storage improves hepatobiliary function of extended criteria donor livers,” Transplantation, vol. 100, no. 4, pp. 825–835, 2016. View at Publisher · View at Google Scholar